Invention Grant
- Patent Title: Targeted cryptosporidium biocides
- Patent Title (中): 靶向隐孢子虫杀生物剂
-
Application No.: US13760448Application Date: 2013-02-06
-
Publication No.: US08703134B2Publication Date: 2014-04-22
- Inventor: Michael Imboden , Michael Riggs , Deborah A. Schaefer , Jane Homan , Robert D. Bremel
- Applicant: ioGenetics, LLC
- Applicant Address: US WI Madison US AZ Tucson
- Assignee: ioGenetics, LLC,Arizona Board of Regents on Behalf of the University of Arizona
- Current Assignee: ioGenetics, LLC,Arizona Board of Regents on Behalf of the University of Arizona
- Current Assignee Address: US WI Madison US AZ Tucson
- Agency: Casimir Jones, S.C.
- Agent Tanya A. Arenson
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/395
Abstract:
The present invention relates to fusion proteins comprising a microorganism targeting molecule (e.g., immunoglobulin) and a biocide. The present invention also relates to therapeutic and prophylactic methods of using a fusion protein comprising a microorganism targeting molecule and a biocide in diverse fields.
Public/Granted literature
- US20130230516A1 TARGETED CRYPTOSPORIDIUM BIOCIDES Public/Granted day:2013-09-05
Information query
